Shanghai Titan Scientific Co., Ltd. Share Price

Equities

688133

CNE100005XG3

Specialty Chemicals

End-of-day quote Shanghai S.E. 03:30:00 09/05/2024 am IST 5-day change 1st Jan Change
30.28 CNY +1.20% Intraday chart for Shanghai Titan Scientific Co., Ltd. +5.10% -34.67%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site

Financials

Sales 2023 2.77B 384M 32.01B Sales 2024 * 3.19B 442M 36.87B Capitalization 3.57B 494M 41.27B
Net income 2023 72M 9.97M 832M Net income 2024 * 100M 13.84M 1.16B EV / Sales 2023 1.97 x
Net cash position 2023 * - 0 0 Net cash position 2024 * - 0 0 EV / Sales 2024 * 1.12 x
P/E ratio 2023
74.8 x
P/E ratio 2024 *
35.5 x
Employees 1,381
Yield 2023
0.22%
Yield 2024 *
0.36%
Free-Float 63.28%
More Fundamentals * Assessed data
Dynamic Chart
Shanghai Titan Scientific Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Shanghai Titan Scientific Co., Ltd. agreed to acquire 30% stake in Shanghai Magal Scientific Instrument Co., Ltd. from Wu Gang and Ling Hui. CI
Shanghai Titan Scientific Co., Ltd. agreed to acquire 26.6667% stake in RADOBIO Scientific Co., Ltd. CI
Shanghai Magal Scientific Instrument Co., Ltd. announced that it expects to receive CNY 12 million in funding from Shanghai Titan Scientific Co., Ltd., Shanghai Titan Heyuan I Venture Capital Investment Partnership Enterprise (Limited Partnership) CI
RADOBIO Scientific Co., Ltd. announced that it expects to receive CNY 16 million in funding from Shanghai Titan Scientific Co., Ltd., Shanghai Titan Heyuan I Venture Capital Investment Partnership Enterprise (Limited Partnership) CI
Shanghai Titan Scientific Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Shanghai Titan Scientific Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Shanghai Titan Scientific Co., Ltd.(XSSC:688133) added to S&P Global BMI Index CI
Shanghai Titan Scientific Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Milestone® Biotechnologies announced that it has received CNY 100 million in funding from Haichuang Tiancheng Equity Investment Fund Management Co., Ltd., Jiangsu Addor Equity Investment Fund Management Co., Ltd., GL Ventures, Shanghai Titan Scientific Co., Ltd., Jiaxing Tongyu Private Equity Fund Management Co., Ltd. CI
Shanghai Titan Scientific Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Shanghai Titan Scientific Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Shanghai Titan Scientific Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Shanghai Titan Scientific Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
More news
1 day+1.20%
1 week+5.10%
Current month+5.10%
1 month+3.95%
3 months-6.49%
6 months-45.13%
Current year-34.67%
More quotes
1 week
29.01
Extreme 29.01
31.35
1 month
24.51
Extreme 24.51
31.35
Current year
24.51
Extreme 24.51
47.02
1 year
24.51
Extreme 24.51
84.84
3 years
24.51
Extreme 24.51
239.27
5 years
24.51
Extreme 24.51
239.27
10 years
24.51
Extreme 24.51
239.27
More quotes
Managers TitleAgeSince
Founder 43 18/07/18
Founder 42 18/07/18
Founder 43 18/07/18
Members of the board TitleAgeSince
Director/Board Member 60 30/23/30
Founder 42 18/07/18
Founder 42 18/07/18
More insiders
Date Price Change Volume
09/24/09 30.28 +1.20% 1,204,476
08/24/08 29.92 -2.03% 1,487,137
07/24/07 30.54 +0.49% 1,297,090
06/24/06 30.39 +5.48% 1,674,251

End-of-day quote Shanghai S.E., May 09, 2024

More quotes
Shanghai Titan Scientific Co Ltd is a China-based company principally engaged in the research and development, production and sales of scientific research reagents, specialty chemicals, scientific research instruments and consumables, as well as providing laboratory construction and scientific research information services. The Company distributes its products through its own brands and third-party brands. The Company mainly distributes its products in domestic market.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
30.28 CNY
Average target price
36.87 CNY
Spread / Average Target
+21.75%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 688133 Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW